Previous 10 | Next 10 |
Rockwell Medical's (RMTI) Q4 2018 Results Earnings Conference Call March 14, 2019, 08:30 AM ET Company Participants Judy DiClemente - In-Site Communications Stuart Paul - President and CEO Angus Smith - CFO Conference Call Participants David Bouchey - IFS Securities Pres...
Rockwell Medical (NASDAQ: RMTI ): Q4 GAAP EPS of -$0.17. More news on: Rockwell Medical, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
WIXOM, Mich., March 14, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (the "Company"), a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD), today reported financial results for the three months and full year ended December 31...
WIXOM, Mich., March 06, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the “Company”) (Nasdaq: RMTI) today announced that the Company will release its 2018 fourth quarter and full year financial results on Thursday, March 14, 2019, before the opening of...
WIXOM, Mich., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the 2019 BIO CEO & Investor Conference as follows: The presentation will be webcast l...
WIXOM, Mich., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at Biotech Showcase™ 2019 during the J.P. Morgan Annual Healthcare Conference as follows...
WIXOM, Mich. , Dec. 10, 2018 /PRNewswire/ -- Rockwell Medical, Inc. (NASDAQ: RMTI) (the "Company" or "Rockwell Medical") today announced that Michael DeYoung has been appointed Vice President, Operations, effective immediately. Mr. DeYoung will report to Stuart Paul , President and Chi...
WIXOM, Mich. , Nov. 1, 2018 /PRNewswire/ -- Rockwell Medical, Inc. (NASDAQ:RMTI) (the "Company" or "Rockwell Medical") today announced that Angus Smith has been appointed as Chief Financial Officer of the Company, effective at the end of November 2018 . Mr. Smith will be responsib...
WIXOM, Mich. , Oct. 29, 2018 /PRNewswire/ -- Rockwell Medical, Inc. (NASDAQ: RMTI) today announced that it will hold a conference call to discuss third quarter 2018 financial results on Friday, November 9, 2018 , at 8:30 am Eastern Time . This call is also being webcast and can ...
Clovis Oncology (NASDAQ: CLVS ) resumed with Neutral rating and $33 (10% upside) price target at Piper Jaffray. Shares up 11% premarket on Rubrace data in mCRPC. More news on: Clovis Oncology, Immunomedics, Inc., Quest Diagnostics Incorporated, Healthcare stocks news, Stocks on...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...